During the past decade, Ospedale Mater Salutis conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Mater Salutis" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "European Institute of Oncology" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Agennix" with 1 trials sponsored and "Associazione Portatori Dispositivi Impiantabili Cardiaci" with 1 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Mater Salutis" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator and "Azienda Ospedaliera Universitaria Integrata Verona" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Mater Salutis" are "Heart Failure" (4 trials), "Breast Neoplasms" (3 trials), "Breast Cancer" (2 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials) and "Adenocarcinoma of the Stomach" (1 trials). Many other conditions were trialed in "Ospedale Mater Salutis" in a lesser frequency.

Most popular intervention types in "Ospedale Mater Salutis" are "Drug" (27 trials), "Device" (4 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (7 trials), "Placebo" (5 trials), "Carboplatin" (4 trials), "Trastuzumab" (4 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Mater Salutis" are 30 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Mater Salutis". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Ospedale Mater Salutis, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Mater Salutis, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".

Ospedale Mater Salutis has several departments that took part in Clinical trials: "Ospedale G. Fracastoro - U.O.C. Di Cardiologia" - 5 trials, "UOC Oncologia Medica, Azienda ULSS21 di Legnago" - 2 trials